Persistence Pays Off: Development of HBV ribonuclease H inhibitors

-
1-125 CCRB

IMV Innovations in Virus Research Antiviral drug target identification and development

Speaker: John Tavis, Ph.D., St. Louis University
Title: "Persistence pays off: Development of HBV ribonuclease H inhibitors"
Date: Wednesday, April 5, 2023
Time: Noon-1pm
Location: 1-125 CCRB
Host: Christopher Belica, IMVTP Fellow